Genetics and prescription opioid use (GaPO): study design for consenting a cohort from an existing biobank to identify clinical and genetic factors influencing prescription opioid use and abuse

Peer Review reports

Original Submission
7 Jul 2021	Submitted	Original manuscript
13 Oct 2021	Author responded	Author comments - Vanessa Troiani
Resubmission - Version 2
13 Oct 2021	Submitted	Manuscript version 2
14 Oct 2021	Author responded	Author comments - Vanessa Troiani
Resubmission - Version 3
14 Oct 2021	Submitted	Manuscript version 3
Publishing
15 Oct 2021	Editorially accepted
26 Oct 2021	Article published	10.1186/s12920-021-01100-z

Back to article page